Cooper ZA, Reuben A, Spencer CN, Prieto PA, Austin-Breneman JL, Jiang H, Haymaker C, Gopalakrishnan V, Tetzlaff MT, Frederick DT, Sullivan RJ, Amaria RN, Patel SP, Hwu P, Woodman SE, Glitza IC, Diab A, Vence LM, Rodriguez-Canales J, Parra ER, Wistuba II, Coussens LM, Sharpe AH, Flaherty KT, Gershenwald JE, Chin L, Davies MA , Clise-Dwyer K, Allison JP, Sharma P, Wargo JA
For many women, that focus can be a game-changer: rather than treating weight as something separate from the rest of your health, Allara looks at how hormones, chronic conditions and metabolism all intersectespecially when those factors make progress feel harder than it should be
Understanding the differences helps you have a more productive conversation with your provider
Analysis by MavenBio highlights that while other pharma companies have broad, diversified portfolios Lilly is the most concentrated large pharma companies: cardiometabolic therapies generated $13.8B, representing over 78% of total pharma revenue